US › Healthcare

Rezolute Inc (RZLT)

US · Healthcare · Biotechnology

$4.97+1.22%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-16.2M
Profit YoY
+14.5%
EPS
$-0.16
EPS estimate
$-0.17

EPS came in at -0.16 against a street estimate of -0.17 — a beat of 8.0%.

Key statistics

Market cap
$472.8M
Forward P/E
0.0
P/B
3.90
Book value
$1.12
EPS (TTM)
$-0.81
52-week high
$11.46
52-week low
$1.07
50-day MA
$4.49
200-day MA
$4.71
Beta
0.62

Analyst view

Analysts rate Rezolute Inc a strong buy (10 buy, 0 hold, 0 sell out of 10) with an average price target of $7.67.

Shareholding

Insiders
10.15%
Institutions
90.63%

Largest institutional holders

FundStake
Federated Hermes Inc13.49%
RA Capital Management, LLC9.53%
BlackRock Inc6.56%
Opaleye Management Inc6.54%
Balyasny Asset Management LLC5.24%
Vanguard Capital Management, LLC3.66%
Jennison Associates LLC3.57%
Siren, L.L.C.3.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Rezolute Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.